Celyad SA (Belgium) Today
| CYAD Stock | EUR 0.33 0.01 2.94% |
Performance0 of 100
| Odds Of DistressLess than 11
|
Celyad SA is selling at 0.33 as of the 18th of April 2024; that is -2.94 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.31. Celyad SA has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Celyad SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of May 2023 and ending today, the 18th of April 2024. Click here to learn more.
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor-T cell-based therapies for the treatment of cancer. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. The company has 22.59 M outstanding shares. More on Celyad SA
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Celyad Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Celyad SA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Celyad SA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Christian Homsy |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Celyad SA (CYAD) is traded on Euronext Brussels in Belgium and employs 95 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 28.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Celyad SA's market, we take the total number of its shares issued and multiply it by Celyad SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Celyad SA operates under Biotechnology sector and is part of Health Care industry. The entity has 22.59 M outstanding shares.
Celyad SA has accumulated about 12.13 M in cash with (26.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Celyad SA Probability Of Bankruptcy
Ownership AllocationCelyad SA holds a total of 22.59 Million outstanding shares. Celyad SA shows 8.83 percent of its outstanding shares held by insiders and 24.19 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Celyad Ownership Details
Celyad Stock Price Odds Analysis
In regard to a normal probability distribution, the odds of Celyad SA jumping above the current price in 90 days from now is over 95.77%. The Celyad SA probability density function shows the probability of Celyad SA stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 1.0389 suggesting Celyad SA market returns are sensible to returns on the market. As the market goes up or down, Celyad SA is expected to follow. Additionally, celyad SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Celyad SA to move above the current price in 90 days from now is over 95.77 (This Celyad SA probability density function shows the probability of Celyad Stock to fall within a particular range of prices over 90 days) .
Celyad SA Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Celyad SA market risk premium is the additional return an investor will receive from holding Celyad SA long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Celyad SA. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Celyad SA's alpha and beta are two of the key measurements used to evaluate Celyad SA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.71 | |||
| Standard Deviation | 4.25 | |||
| Variance | 18.1 | |||
| Risk Adjusted Performance | 0.0017 |
Celyad Stock Against Markets
Picking the right benchmark for Celyad SA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Celyad SA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Celyad SA is critical whether you are bullish or bearish towards Celyad SA at a given time. Please also check how Celyad SA's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Celyad SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Celyad SA Corporate Directors
Celyad SA corporate directors refer to members of a Celyad SA board of directors. The board of directors generally takes responsibility for the Celyad SA's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Celyad SA's board members must vote for the resolution. The Celyad SA board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Jaak Minten | Director Clinical Affairs, representing Fakkel SPRL | Profile | |
| Roland GordonBeresford | Regulatory Affairs and IP Director | Profile | |
| William Wijns | Non-Executive Director, permanent representative of the Cardiovascular Center Aalst CVBA | Profile | |
| Hanspeter Spek | Non-Executive Director | Profile |
How to buy Celyad Stock?
Before investing in Celyad SA, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Celyad SA. To buy Celyad SA stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Celyad SA. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Celyad SA stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Celyad SA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Celyad SA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Celyad SA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Celyad SA?
The danger of trading Celyad SA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Celyad SA is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Celyad SA. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Celyad SA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celyad SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Celyad Stock analysis
When running Celyad SA's price analysis, check to measure Celyad SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celyad SA is operating at the current time. Most of Celyad SA's value examination focuses on studying past and present price action to predict the probability of Celyad SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celyad SA's price. Additionally, you may evaluate how the addition of Celyad SA to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |